These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16294367)

  • 1. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
    Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity induced by antiandrogens: a review of the literature.
    Thole Z; Manso G; Salgueiro E; Revuelta P; Hidalgo A
    Urol Int; 2004; 73(4):289-95. PubMed ID: 15604569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant hepatic failure associated with bicalutamide.
    Schellhammer PF
    Urology; 1997 Nov; 50(5):827. PubMed ID: 9372905
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
    Lin AD; Chen KK; Lin AT; Chang YH; Wu HH; Kuo JY; Huang WJ; Hsu YS; Chung HJ; Chang LS
    J Chin Med Assoc; 2003 Dec; 66(12):735-40. PubMed ID: 15015823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
    Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M
    Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.
    Manolakopoulos S; Bethanis S; Armonis A; Economou M; Avgerinos A; Tzourmakliotis D
    Dig Dis Sci; 2004 Mar; 49(3):462-5. PubMed ID: 15139499
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis.
    Pu YS; Liu CM; Kao JH; Chen J; Lai MK
    Eur Urol; 1999 Oct; 36(4):293-7. PubMed ID: 10473987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
    Schröder FH
    Prog Clin Biol Res; 1990; 359():93-103; discussion 105-7. PubMed ID: 2149460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of adverse drug reactions induced by flutamide and bicalutamide: a real-world pharmacovigilance study using FAERS.
    Sun Y; Xu T; Zhu S; Xu H
    Expert Opin Drug Saf; 2024 Mar; 23(3):305-311. PubMed ID: 37795911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
    Sciarra A; Cardi A; Di Silverio F
    Urol Int; 2004; 72(2):91-8. PubMed ID: 14963347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancer.
    Blackledge G; Kolvenbag G; Nash A
    Anticancer Drugs; 1996 Jan; 7(1):27-34. PubMed ID: 8742095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer].
    Satoh T; Egawa S; Katsuta M; Iwamura M; Uchida T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):694-6. PubMed ID: 9267134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
    Nguyen TV; Yao M; Pike CJ
    Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogen treatments in locally advanced prostate cancer: are they all the same?
    Gillatt D
    J Cancer Res Clin Oncol; 2006 Aug; 132 Suppl 1():S17-26. PubMed ID: 16845534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicalutamide-associated fulminant hepatic failure.
    Chodak GW
    Urology; 1997 Dec; 50(6):1027. PubMed ID: 9426744
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
    Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
    Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
    Akakura K; Furuya Y; Ito H
    Nihon Rinsho; 1998 Aug; 56(8):2124-8. PubMed ID: 9750520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of change to flutamide for prostate cancer patient who developed breast pain during bicalutamide treatment (BIP-F study)].
    Kitamura Y; Okuno H; Sakura Y; Manabe Y; Masuda N; Ito H; Mishina M; Taoka R; Terai A; Sugimoto M; Kakehi Y
    Hinyokika Kiyo; 2014 Jan; 60(1):17-23. PubMed ID: 24594768
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.